Rock Springs Capital Management LP Amicus Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $2.94 Billion
- Q3 2024
A detailed history of Rock Springs Capital Management LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 1,250,280 shares of FOLD stock, worth $12.3 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
1,250,280
Previous 1,218,580
2.6%
Holding current value
$12.3 Million
Previous $12.1 Million
10.46%
% of portfolio
0.45%
Previous 0.37%
Shares
10 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
314MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$282 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$275 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$239 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$235 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$227 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.75B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...